Lung CA™

About Behavioral Diagnostics

Behavioral Diagnostics is a private, commercial-stage diagnostics company pioneering epigenetic tests for behavioral health and oncology risk stratification. Its technology platform analyzes DNA methylation patterns from blood or saliva to objectively quantify smoking and alcohol consumption, and to assess personalized lung cancer risk, addressing significant gaps in self-reported data and preventive screening. The company targets multiple customer segments including healthcare providers, insurers, employers, and direct-to-consumer patients, positioning its tests as tools for shared decision-making, underwriting, workplace wellness, and personal health monitoring. Backed by NIH-funded research and a deep product pipeline, it aims to revolutionize early detection and preventive care.

Therapeutic Areas